L2M Validation / Qc Automne 2025 / Validating Market Fit for a Cardiac Fibrosis-Preventing Drug

This project aims to explore the market potential of a new drug screening approach by Telescope Therapeutics that uses human stem cells to create a more accurate model for studying and testing treatments for heart scarring, known as cardiac fibrosis. By better understanding the needs and interests of potential users like pharmaceutical companies and research organizations, the project will help Telescope refine its business strategy and find the best path to bring this innovative technology to market. Ultimately, this will support the company’s goal to develop effective new therapies/drug that could improve the lives of patients with heart disease and strengthen Telescope’s position in the biotech industry.

Faculty Supervisor:

Jason Tanny

Student:

Partner:

V1 Studio

Discipline:

Life Sciences

Sector:

Biotechnology; Health and Related Sciences & Technology

University:

McGill University

Program: